Lv1
46 积分 2024-12-30 加入
Combination Biologic Treatment of Refractory Psoriasis and Psoriatic Arthritis
1天前
待确认
Discovery and preclinical evaluation of KYS202004A, a novel bispecific fusion protein targeting TNF-α and IL-17A, in autoimmune disease models
7天前
已完结
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
7天前
已完结
皖公网安备34019202002308
